Mondor's disease is an unusual and little-known pathology of the breast, characterized by superficial thrombophlebitis. The causes are still unresolved. Most of the patients do not fall under case studies of the scientific literature, given the reported incidence rate between 0.5% and 0.8%. The Mondor's disease patients are not always properly identified, and they are frequently treated as outpatients, even considering the benign course of the disease which often spontaneously resolves without any medical therapy. We report here six new cases of Mondor's disease, two of them were likely due to a trauma and were easily resolved with the use of non-steroidal anti-inflammatory drugs; the third one was apparently due to the stretching of the mammary veins in a patient with gigantomastia; the fourth one was subsequent to hormonal stimulation for in vivo fertilization and following gestation; and the last two cases (one was a man) were diagnosed after undergoing surgery for breast carcinoma.
Breast chondrosarcoma is a rare sarcoma that mainly occurs in females >50 years old. To the best of our knowledge, only 16 cases were reported in the literature prior to 2013 and all patients were surgically treated by mastectomy, with or without lymphadenectomy, which was occasionally preceded by neoadjuvant chemotherapy. However, the literature does not report the benefit of mastectomy compared with a more conservative surgery. The present study reports a novel case of extraskeletal chondrosarcoma of the breast. A 63-year-old female patient presented with a neoplasm localized in the upper-outer quadrant of the right breast. The palpable lesion with sharp margins was a firm parenchymatous mass, which was confirmed by ultrasonography and mammography. The patient underwent conservative quadrantectomy instead of mastectomy, followed by post-surgical chemotherapy. A positron emission tomography scan performed five months subsequent to the surgery revealed no remnants of the disease. The patient underwent a strict clinical and instrumental follow-up, and two and half years after surgery, there are no signs of recurrent disease. In conclusion, the present case is currently one of the two cases in which a more conservative quadrantectomy was performed, instead of mastectomy. This surgical approach did not lead to metastasis and resulted in a good follow-up for the patient.
Background Cricothyrotomy consists in the creation of a percutaneous opening of the upper airway at the easiest and most rapidly accessible level, i.e. the cricothyroid membrane, through which a respiratory cannula is introduced to be connected to the ventilatory system (1). This surgical procedure was initially performed in the 20's as alternative to "high tracheostomy" that became rarely used because of a subglottic stenosis after tracheostomy described in 158 cases (1, 2). In the anesthesia literature, cricothyrotomy is indicated for the management of the so-called "difficult airways", or "can't intubate, can't oxygenate" conditions, i.e. all those clinical situation, defined by the American Society of Anesthesiologists in which there is a lack of control of the airways due to either failure of oral/nasal endotracheal intubation or supraglottic obstruction of the upper airway (3-5). Such situations can be represented, especially in emergency, by anatomical abnormalities of the airways, oral and maxillofacial traumas, suspected cervical spinal injury, obesity, emesis, oral hemorrhage, which obstruct the visualization of the vocal cords (3-6). In such a scenario, cricothyrotomy is the only procedure that allows re-establishing oxygenation quickly enough to prevent the consequences of SUMMARY: Cricothyrotomy performed with the Melker™ set or the QuickTrach™ kit: procedure times, learning curves and operators' preference.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.